PL1699474T5 - Tabletkowe preparaty probiotyczne - Google Patents

Tabletkowe preparaty probiotyczne

Info

Publication number
PL1699474T5
PL1699474T5 PL04804142T PL04804142T PL1699474T5 PL 1699474 T5 PL1699474 T5 PL 1699474T5 PL 04804142 T PL04804142 T PL 04804142T PL 04804142 T PL04804142 T PL 04804142T PL 1699474 T5 PL1699474 T5 PL 1699474T5
Authority
PL
Poland
Prior art keywords
zone
organism
probiotic
micro
probiotic micro
Prior art date
Application number
PL04804142T
Other languages
English (en)
Other versions
PL1699474T3 (pl
Inventor
Kristian Lund Henriksen
Helene Mathilda Mortensen
Marianne Winning
Original Assignee
Ferrosan As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=30776514&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1699474(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ferrosan As filed Critical Ferrosan As
Publication of PL1699474T3 publication Critical patent/PL1699474T3/pl
Publication of PL1699474T5 publication Critical patent/PL1699474T5/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PL04804142T 2003-12-24 2004-12-21 Tabletkowe preparaty probiotyczne PL1699474T5 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0330009.2A GB0330009D0 (en) 2003-12-24 2003-12-24 Probiotic tablet formulations
EP04804142.0A EP1699474B2 (en) 2003-12-24 2004-12-21 Probiotic tablet formulations
PCT/EP2004/014545 WO2005063200A2 (en) 2003-12-24 2004-12-21 Probiotic tablet formulations

Publications (2)

Publication Number Publication Date
PL1699474T3 PL1699474T3 (pl) 2010-06-30
PL1699474T5 true PL1699474T5 (pl) 2014-02-28

Family

ID=30776514

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04804142T PL1699474T5 (pl) 2003-12-24 2004-12-21 Tabletkowe preparaty probiotyczne

Country Status (15)

Country Link
US (2) US10172793B2 (pl)
EP (1) EP1699474B2 (pl)
CN (1) CN1913905B (pl)
AT (1) ATE453397T1 (pl)
AU (1) AU2004308632B2 (pl)
CA (1) CA2551581A1 (pl)
DE (1) DE602004024924D1 (pl)
DK (1) DK1699474T4 (pl)
EA (1) EA011321B1 (pl)
ES (1) ES2336680T5 (pl)
GB (1) GB0330009D0 (pl)
NO (1) NO340908B1 (pl)
PL (1) PL1699474T5 (pl)
UA (1) UA87296C2 (pl)
WO (1) WO2005063200A2 (pl)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
ATE512211T1 (de) 2005-05-31 2011-06-15 Iams Company Feline probiotische lactobacilli
PL1885383T3 (pl) 2005-05-31 2017-06-30 Iams Europe B.V. Kocie probiotyczne bifidobakterie
PT1928426E (pt) * 2005-09-29 2014-12-02 Merck Patent Gmbh Processo para a estabilização de formas farmacêuticas que contêm microrganismos
AU2012244263B2 (en) * 2005-10-12 2015-09-17 Genencor International, Inc. Stable, durable granules with active agents
US8524304B2 (en) * 2005-11-23 2013-09-03 The Coca-Cola Company High-potency sweetener composition with probiotics/prebiotics and compositions sweetened therewith
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
US20080241805A1 (en) 2006-08-31 2008-10-02 Q-Track Corporation System and method for simulated dosimetry using a real time locating system
US9084434B2 (en) * 2006-09-27 2015-07-21 Little Calumet Holdings Llc Probiotic oral dosage forms
BRPI0808391A2 (pt) 2007-02-01 2014-07-08 Lams Company Método para diminuir a inflamação e o estresse em um mamífero, mediante o uso de antimetabólitos de glicose, abacate ou extratos de abacate.
CN101273738B (zh) * 2007-03-28 2011-06-01 哈尔滨正方科技有限公司 在常温下保持高活菌数的调配型酸性乳饮料的制备方法
US9078824B2 (en) * 2007-09-24 2015-07-14 The Procter & Gamble Company Composition and method of stabilized sensitive ingredient
CN101259278B (zh) * 2008-04-21 2010-06-02 黄芝芳 一种含抑菌剂的多种水溶性维生素的药物组合物及其制备方法
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
EP2210593A3 (en) * 2009-01-21 2011-05-18 DSM IP Assets B.V. Tablettable formulations of vitamin A and derivatives thereof
WO2010114864A1 (en) * 2009-04-01 2010-10-07 Little Calumet Holdings, Llc Probiotic oral dosage forms
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
KR101102364B1 (ko) * 2009-09-18 2012-01-03 한림제약(주) 비스포스포네이트 유도체 및 고용량의 콜레칼시페롤을 포함하는 약학 조성물
US20120107395A1 (en) * 2010-11-01 2012-05-03 Viva Pharmaceutical Inc. Probiotic Soft Gel Compositions
IT1403661B1 (it) * 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITRM20110477A1 (it) 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
DE102011122250A1 (de) * 2011-10-24 2013-04-25 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Eisenhaltige Vitaminzusammensetzung
ITMI20130793A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
US9717767B2 (en) * 2014-05-12 2017-08-01 BiOWiSH Technologies, Inc. Compositions and methods for improving human health and nutrition
AP2016009641A0 (en) * 2014-07-01 2016-12-31 Probi Usa Inc Bi-layer dual release probiotic tablets
CN104489646B (zh) * 2014-11-19 2016-08-31 李雅君 一种果蔬益生菌片剂及其制备方法
CN108135240B (zh) 2015-05-11 2022-06-17 迈彼欧提克斯制药有限公司 用于使益生菌在使细菌于肠道中定植用途的固体颗粒上生长成益生菌生物膜的系统和方法
JP7017849B2 (ja) * 2015-09-11 2022-02-09 シムライズ アーゲー 経口投与剤形
US9907323B2 (en) 2015-09-25 2018-03-06 Mead Johnson Nutrition Co. Infant formula tablets
CN108778300A (zh) * 2015-10-07 2018-11-09 拜福丹公司 益生菌制剂
WO2017065623A1 (en) * 2015-10-16 2017-04-20 Mendoza Wendell Stable composition of vitamin c and zinc tablet
MA45334A (fr) 2016-03-24 2019-01-30 Probiotical Spa Composition bactérienne d'acide lactique pour le traitement d'infections vaginales bactériennes par gardnerella vaginalis et, éventuellement, d'infections fongiques concurrentes
CN105962376A (zh) * 2016-04-28 2016-09-28 内蒙古乌审召生态产业发展有限公司 一种具有层结构的螺旋藻片及其制备方法
RU2022101485A (ru) 2016-05-25 2022-04-27 Майбиотикс Фарма Лтд. Композиция и способы для микробиотной терапии
AU2017358709B2 (en) 2016-11-10 2022-08-25 Société des Produits Nestlé S.A. Composition in powder form comprising iron and probiotic bacteria
PH12019550052B1 (en) * 2016-12-15 2023-10-25 Socia‰Ta‰ Des Produits Nestla‰ S A Composition in powder form comprising iron-milk protein complexes and probiotic bacteria
IT201700011337A1 (it) * 2017-02-02 2018-08-02 S I I T S R L Servizio Int Imballaggi Termosaldanti Compressa multistrato per la somministrazione di magnesio
CN107821753A (zh) * 2017-11-20 2018-03-23 江苏雅博动物健康科技有限责任公司 一种宠物用益生菌颗粒制剂及其制备方法
WO2019101832A1 (en) * 2017-11-27 2019-05-31 Dsm Ip Assets B.V. Freeze-dried multiparticulate solid dosage form
CA3096300A1 (en) 2018-05-29 2019-12-05 BiOWiSH Technologies, Inc. Compositions and methods for improving survivability of aquatic animals
US11254619B2 (en) 2019-04-12 2022-02-22 Jeffrey Hanson Robbins Dry composition including effervescent agents, biostimulant, and plant nutrient
US11247944B2 (en) 2019-04-12 2022-02-15 Jeffrey Hanson Robbins Potassium citrate mixture formed from a dry fertilizer and methods thereof
KR20210152505A (ko) * 2019-04-15 2021-12-15 인스티튜트 디＇인베스티가시온스 바이오메디퀘스 아우구스트 피 아이 수니에르 장기간 안정하게 살아있는 대변 미생물총 조성물
CN110934751B (zh) * 2019-12-31 2022-09-02 成都三勒浆药业集团四川华美制药有限公司 一种用于口腔健康的双层口含片及其制备方法
FR3125945B1 (fr) * 2021-08-03 2024-07-12 Setalg Composition pour protéger un microorganisme dans un environnement acide.
GR1010840B (el) * 2023-10-02 2024-12-18 Geoplan Nutraceuticals Ike, Συνθεσεις στοματικα διασπειρομενων δισκιων με προβιοτικα, ψευδαργυρο και βιταμινη c

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52102419A (en) * 1976-02-23 1977-08-27 Seikenkai Lactic acid producing bacillus preparation
EP0116736B1 (en) † 1983-02-18 1987-02-25 NABISCO BRANDS, Inc. Canine biscuit containing discrete meat and/or meat by-product particles and method for making same
US4956295A (en) † 1984-05-21 1990-09-11 Chr. Hansen's Laboratory, Inc. Stabilization of dried bacteria extended in particulate carriers
JPH0780754B2 (ja) * 1986-08-06 1995-08-30 エーザイ株式会社 多顆粒型持続性錠剤
IL98087A (en) * 1990-05-04 1996-11-14 Perio Prod Ltd Preparation for dispensing drugs in the colon
US5310555A (en) † 1992-07-24 1994-05-10 Midwestern Bio-Ag Products And Services, Inc. Oral nutritional and dietary composition
US5885481A (en) * 1993-07-16 1999-03-23 Amoco Corporation Efficiency oxygen-scavenging compositions and articles
FR2716341B1 (fr) † 1994-02-23 1996-05-10 Gervais Danone Sa Composition alimentaire comportant un biscuit ou une coque de chocolat et un fourrage à base de produit laitier, fermenté ou non .
GB9422154D0 (en) * 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
SE513815C2 (sv) 1995-08-25 2000-11-06 Wasa Medicals Ab Förfarande för framställning av tabletter innehållande levande mikroorganismer och med oligosacharider i tablettmaterialet
US5774056A (en) * 1996-05-30 1998-06-30 Engineered Products Co. Gauge for monitoring air filters
US6083585A (en) * 1996-09-23 2000-07-04 Bp Amoco Corporation Oxygen scavenging condensation copolymers for bottles and packaging articles
GB2323532B (en) * 1997-03-27 2001-08-22 Bakulesh Mafatlal Khamar Process for the preparation of a stable fixed dose pharmaceutical composition of anti-infective agent(s) and micro organisms as active ingredients
NZ503086A (en) * 1997-08-29 2002-03-01 Upjohn Co An orally administrable pharmaceutical composition comprising an inner core and two outer layers, which render it substantially free of unpleasant tastes
SI0931543T1 (en) * 1997-12-19 2002-10-31 Merck Patent Gmbh Multilayered tablet comprising probiotic microorganisms such as lactobacilli or bifidobacteria
US6169387B1 (en) 1997-12-22 2001-01-02 Lifecor, Inc. Battery management apparatus for portable electronic devices
DE19819475A1 (de) † 1998-04-30 1999-11-04 Basf Ag Trockene Mikroorganismen-Kulturen und Verfahren zu deren Herstellung
ES2165139T3 (es) 1998-04-30 2002-03-01 Vesely Renata Maria Cavaliere Composiciones farmaceuticas que contienen lactobacillus brevis y lactobacillus salivarius para el tratamiento de infecciones vaginales.
CA2339643A1 (en) 1998-08-07 2000-02-17 Ganeden Biotech, Inc. Methods for increasing the solubility of nutritional materials using probiotic lactic acid-producing bacteria
DE69932030T2 (de) † 1999-04-09 2007-01-04 Société des Produits Nestlé S.A. Roher belegter Pizzateig
CA2281463A1 (en) 1999-08-26 2001-02-26 Stanley H. Zlotkin Composition comprising micronutrients in combination with prebiotics, probiotics, and synbiotics
SE515310C2 (sv) 1999-11-25 2001-07-09 Wasa Medicals Ab Tabletter innehållande mikroorganismer och förfarande för framställning därav
US6399114B2 (en) * 2000-05-26 2002-06-04 C & D Foreman, Inc. Nutritional system for nervous system disorders
GB0027761D0 (en) 2000-11-14 2000-12-27 Nestle Sa Nutritional composition for an immune condition
EP1429802B1 (en) 2001-09-28 2012-11-07 TNTGamble, Inc. Delivery system for biological component
US7101565B2 (en) * 2002-02-05 2006-09-05 Corpak Medsystems, Inc. Probiotic/prebiotic composition and delivery method
DE10206995B4 (de) 2002-02-19 2014-01-02 Orthomol Pharmazeutische Vertriebs Gmbh Mikronährstoffkombinationsprodukt mit Pro- und Prebiotika
DE20202562U1 (de) 2002-02-19 2002-05-23 Orthomol pharmazeutische Vertriebs GmbH, 40764 Langenfeld Mikronährstoffkombinationsprodukt mit Pro- und Prebiotika
EP1344458A1 (en) † 2002-03-12 2003-09-17 Société des Produits Nestlé S.A. Probiotic delivery system
DE60323734D1 (de) 2002-03-21 2008-11-06 Bifodan As Lactobacillus-stämme
EP1449525A1 (en) * 2003-02-20 2004-08-25 Cross Chem Llc chewing gum in the form of multi-layer tablets
US9210945B2 (en) † 2009-07-31 2015-12-15 The Iams Company Animal food having low water activity
AU2010282710B2 (en) † 2009-08-13 2015-01-15 Kellanova Low water activity food binder and methods related thereto

Also Published As

Publication number Publication date
US10172793B2 (en) 2019-01-08
DE602004024924D1 (de) 2010-02-11
CA2551581A1 (en) 2005-07-14
ATE453397T1 (de) 2010-01-15
EP1699474A2 (en) 2006-09-13
CN1913905A (zh) 2007-02-14
NO20063410L (no) 2006-09-22
DK1699474T3 (da) 2010-04-12
PL1699474T3 (pl) 2010-06-30
AU2004308632A1 (en) 2005-07-14
DK1699474T4 (da) 2013-12-02
EA011321B1 (ru) 2009-02-27
NO340908B1 (no) 2017-07-10
WO2005063200A2 (en) 2005-07-14
US20190091145A1 (en) 2019-03-28
UA87296C2 (en) 2009-07-10
US20070269515A1 (en) 2007-11-22
ES2336680T3 (es) 2010-04-15
CN1913905B (zh) 2010-09-08
AU2004308632B2 (en) 2010-07-01
EA200601214A1 (ru) 2006-12-29
WO2005063200A3 (en) 2005-11-24
EP1699474B1 (en) 2009-12-30
EP1699474B2 (en) 2013-10-23
GB0330009D0 (en) 2004-01-28
ES2336680T5 (es) 2014-01-20

Similar Documents

Publication Publication Date Title
GB0330009D0 (en) Probiotic tablet formulations
Wu et al. Effect of probiotic Bacillus subtilis Ch9 for grass carp, Ctenopharyngodon idella (Valenciennes, 1844), on growth performance, digestive enzyme activities and intestinal microflora
DK0973413T3 (da) Levnedsmiddelformuleringer indeholdende lacto-N-neotetraose
AU7038600A (en) Extracts derived from pueraria mirifica, butea superba and/or mucuna collettii and extraction thereof
DE69924141D1 (de) Orale verabreichung von laktobacillus zur behandlung und prävention von urogenitalen infektionen
UA95967C2 (ru) Препаративная форма для локального местного введения, содержащая индоксакарб
DK2288360T3 (da) Isoleret Lactobacillus plantarum-stamme Inducia DSM21379 som probiotikum, som forøger naturlig immunitet, samt fødevareprodukter og medicinske præparater omfattende den
DE59706697D1 (de) Mehrschichttablette enthaltend probiotische Mikroorganismen wie z.B. Lactobacilli oder Bifidobakterien
IL156490A0 (en) Probiotic compounds derived from lactobacillus casei strain ke01
EP1408776A4 (en) NEW BETA-CONTAINING FOOD PRODUCTS
AU2002243005A1 (en) Vital cell preparations containing lactic acid bacterium as the active ingredient and lactic acid bacterium-containing foods
UA86349C2 (ru) Противоаллергический агент, его применение для снижения аллергии и способ уменьшения симптомов аллергии
TR200200301T2 (tr) Patojenik bakterilerin sebep olduğu ishali ölemeye elverişli bifidobakteriler
EP1249179A4 (en) SUSPENDED FOOD ADDITIVE COMPOSITIONS AND FOOD COMPOSITIONS CONTAINING SAME
MXPA03008420A (es) Forma farmaceutica solida oralmente dispersa.
FR2827774B1 (fr) Preparations pharmaceutiques et/ou dietetiques contenant un extrait vegetal titre en composes actifs et des micro-organismes probiotiques
TW200700074A (en) Inducer of t cell apoptosis
CA2427080A1 (en) Platelet aggregation inhibitor and supplement food effective for inhibiting platelet aggregation
ATE451110T1 (de) Zusammensetzung mit immunregulierenden wirkungen aus lactobacillus pentosus
DE502005010277D1 (de) Teinen
BR0012973B1 (pt) Uso de bactéria do ácido láctico pertencente ao gênero Bifidobacterium, e composição alimentícia ou farmacêutica.
ATE285757T1 (de) Inaktivierte mikroorganismen, die pharmakologisch aktive substanzen enthalten
ATE435595T1 (de) Tafeloliven, die probiotische mikroorganismen enthalten
EP1547608A4 (en) REMEDIES
RU2001113082A (ru) Состав для изготовления драже